BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

Clinical trial NCT04891068 · RECRUITING

Trial details

NCT number: NCT04891068
Sponsor: University of Illinois at Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Invasive Early-stage Breast Cancer High Risk Breast Carcinoma

Start date: 2022-01-10
Primary completion: 2027-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.